These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7640489)

  • 1. The effect of age on language in people with Down's syndrome.
    Cooper SA; Collacott RA
    J Intellect Disabil Res; 1995 Jun; 39 ( Pt 3)():197-200. PubMed ID: 7640489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dichotic verbal processing in Down's syndrome children having qualitatively different speech and language skills.
    Sommers RK; Starkey KL
    Am J Ment Defic; 1977 Jul; 82(1):44-53. PubMed ID: 142427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of age on language in people with Down's syndrome.
    Prasher VP
    J Intellect Disabil Res; 1996 Oct; 40 ( Pt 5)():484-5. PubMed ID: 8906536
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between speech, oromotor, language and cognitive abilities in children with Down's syndrome.
    Cleland J; Wood S; Hardcastle W; Wishart J; Timmins C
    Int J Lang Commun Disord; 2010; 45(1):83-95. PubMed ID: 19821789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive behaviour after schizophrenia in people with Down's syndrome.
    Cooper SA; Duggirala C; Collacott RA
    J Intellect Disabil Res; 1995 Jun; 39 ( Pt 3)():201-4. PubMed ID: 7640490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal speech to normal and Down's syndrome children matched for mean length of utterance.
    Rondal JA
    Monogr Am Assoc Ment Defic; 1978; (3):193-265. PubMed ID: 155777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial.
    de la Torre R; de Sola S; Hernandez G; Farré M; Pujol J; Rodriguez J; Espadaler JM; Langohr K; Cuenca-Royo A; Principe A; Xicota L; Janel N; Catuara-Solarz S; Sanchez-Benavides G; Bléhaut H; Dueñas-Espín I; Del Hoyo L; Benejam B; Blanco-Hinojo L; Videla S; Fitó M; Delabar JM; Dierssen M;
    Lancet Neurol; 2016 Jul; 15(8):801-810. PubMed ID: 27302362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships amongst age, language and related skills in adults with Down syndrome.
    Iacono T; Torr J; Wong HY
    Res Dev Disabil; 2010; 31(2):568-76. PubMed ID: 20045630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lexical and syntactic development in Italian children with Down's syndrome.
    Zampini L; D'Odorico L
    Int J Lang Commun Disord; 2011; 46(4):386-96. PubMed ID: 21771215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive executive function in Down's syndrome.
    Rowe J; Lavender A; Turk V
    Br J Clin Psychol; 2006 Mar; 45(Pt 1):5-17. PubMed ID: 16480563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epilepsy, dementia and adaptive behaviour in Down's syndrome.
    Collacott RA
    J Intellect Disabil Res; 1993 Apr; 37 ( Pt 2)():153-60. PubMed ID: 8481613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behaviour phenotype for Down's syndrome.
    Collacott RA; Cooper SA; Branford D; McGrother C
    Br J Psychiatry; 1998 Jan; 172():85-9. PubMed ID: 9534839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressive pragmatic skills in pre-school children with and without Down's syndrome: parental perceptions.
    Johnston F; Stansfield J
    J Intellect Disabil Res; 1997 Feb; 41 ( Pt 1)():19-29. PubMed ID: 9089456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of age and residential placement on adaptive behaviour of adults with Down's syndrome.
    Collacott RA
    Br J Psychiatry; 1992 Nov; 161():675-9. PubMed ID: 1422618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The aging of Down's Syndrome subjects].
    Fromage B; Anglade P
    Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verbal and nonverbal interaction of mothers with their down's syndrome and nonretarded infants.
    Buckhalt JA; Rutherford RB; Goldberg KE
    Am J Ment Defic; 1978 Jan; 82(4):337-43. PubMed ID: 146431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study.
    Yang Q; Rasmussen SA; Friedman JM
    Lancet; 2002 Mar; 359(9311):1019-25. PubMed ID: 11937181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
    Hanney M; Prasher V; Williams N; Jones EL; Aarsland D; Corbett A; Lawrence D; Yu LM; Tyrer S; Francis PT; Johnson T; Bullock R; Ballard C;
    Lancet; 2012 Feb; 379(9815):528-36. PubMed ID: 22236802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural problems in children with Down's syndrome and their siblings.
    Cuskelly M; Dadds M
    J Child Psychol Psychiatry; 1992 May; 33(4):749-61. PubMed ID: 1534811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.